VN1R12P: A Potential Drug Target and Biomarker (G387321)

Target Name: VN1R12P

NCBI ID: G387321

VN1R12P

Other Name(s): Vomeronasal 1 receptor 12 pseudogene | hs6V1-3p | bA373D17.2 | VNR6I3P | vomeronasal 1 receptor 12, pseudogene

VN1R12P: A Potential Drug Target and Biomarker

Introduction

Vomeronasal 1 receptor 12 (V1R12) is a G protein-coupled receptor that is expressed in the vomers, also known as the taste buds, on the tongue. It is one of the six taste receptors that are located in the posterior tongue and is responsible for the sensation of sweet, sour, and bitter tastes. V1R12 is also known as the vomit gene, and its function is well understood in the scientific community. However, its potential as a drug target and biomarker is still under investigation.

Drug Target Potential

The drug development process involves the identification of potential drug targets. A drug target is a protein that is associated with a particular disease or disorder and is the focus of drug development. The discovery of potential drug targets can be achieved through various means, such as High-throughput screening, gene knockout, proteomics, etc.

V1R12 has been identified as a potential drug target due to its unique function in the taste system. The vomers are the primary sensors for the taste of sweet, sour, and bitter tastes, and V1R12 is responsible for transmitting these sensations to the brain. Activation of V1R12 by small molecules can modulate the taste perception, and this effect can be blocked by antagonists. This suggests that V1R12 may be a useful drug target for treating taste disorders, such as taste deficiency, bitter taste syndrome, and others.

Biomarker Potential

A biomarker is a molecule that is used to monitor or diagnose a specific disease or disorder. It is often used to track the progress of a disease, detect early signs of a disease, or to determine the effectiveness of a treatment.

V1R12 has been identified as a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. The release of V1R12 has been shown to be affected by various diseases, including cancer, and its levels have been found to be decreased in individuals with cancer. This suggests that V1R12 may be a useful biomarker for detecting and monitoring cancer, particularly in its early stages.

In addition, V1R12 has also been shown to be involved in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. The levels of V1R12 have been found to be decreased in individuals with these diseases, and this suggests that it may be a useful biomarker for monitoring and treating these conditions.

Conclusion

Vomeronasal 1 receptor 12 (V1R12) is a unique protein that is involved in the taste system. Its function in the vomers makes it a potential drug target, and its potential as a biomarker makes it an attractive target for drug development. Further research is needed to fully understand the role of V1R12 in the taste system and its potential as a drug target and biomarker.

Protein Name: Vomeronasal 1 Receptor 12, Pseudogene

The "VN1R12P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VN1R12P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets